Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma
Matrix metalloproteases (MMPs), enzymes with the ability to degrade the extracellular matrix, play an important role in tissue invasion by cutaneous malignant melanoma (CMM). One specific MMP, collagenase-3 (MMP-13), is thought to have a key function in the activation of MMP. To evaluate the express...
Gespeichert in:
| Veröffentlicht in: | The International journal of biological markers 2005-10, Vol.20 (4), p.242-248 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 248 |
|---|---|
| container_issue | 4 |
| container_start_page | 242 |
| container_title | The International journal of biological markers |
| container_volume | 20 |
| creator | CORTE, M. D GONZALEZ, L. O CORTE, M. G QUINTELA, I PIDAL, I BONGERA, M VIZOSO, F |
| description | Matrix metalloproteases (MMPs), enzymes with the ability to degrade the extracellular matrix, play an important role in tissue invasion by cutaneous malignant melanoma (CMM). One specific MMP, collagenase-3 (MMP-13), is thought to have a key function in the activation of MMP.
To evaluate the expression of MMP-13 in CMM and assess its possible relationship to clinical and pathological parameters.
MMP-13 expression was analyzed in 51 paraffin-embedded tumor samples from patients with invasive CMM, ten samples from in situ melanomas, and in eight samples from benign lesions (three dermal melanocytic nevi, three compound melanocytic nevi and two atypical melanocytic nevi) using immunohistochemical techniques. The median follow-up period in patients with invasive CMM was 50 months.
Benign lesions were consistently negative for MMP-13, whereas three of the ten in situ melanomas (30%) and 23 of the 51 invasive CMMs (45%) showed positive immunostaining for MMP-13. The percentage of MMP-13-positive tumors correlated significantly and positively with the mitotic index (p=0.002) in invasive CMM. However, our results did not show any significant association between tumoral MMP-13 expression and relapse-free survival in patients with invasive CMM.
MMP-13 appears to be a factor associated with tumor aggressiveness in CMM. It seems to eliminate an important barrier not only against tumoral invasion but also against proliferation. |
| doi_str_mv | 10.1177/172460080502000407 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69055682</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69055682</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-247d4fa6e6db704b46f27772702febb290f22a7581b4d869fb11aac029dbe0bc3</originalsourceid><addsrcrecordid>eNplkE1Lw0AYhBdRbK3-AQ-Si6KH6LvfybEUv6BFD3oO7252SyTZ1GwD-u9NbcCDp4HhmWEYQs4p3FKq9R3VTCiADCQwABCgD8h0Z6Y795BMgec8VVTKCTmJ8QOAUdDqmEyo4nkmQE3JfNHWNa5dwOhSnlyvVq8p5TeJ-9p0LsaqDUkVEttvMbi2j0mDdbUOGLZJ42oMbYOn5MhjHd3ZqDPy_nD_tnhKly-Pz4v5MrVC0G3KhC6FR-VUaTQII5RnWmumgXlnDMvBM4ZaZtSIMlO5N5QiWmB5aRwYy2fkat-76drP3sVt0VTRumH977JC5SClytgAsj1ouzbGzvli01UNdt8FhWJ3XPH_uCF0Mbb3pnHlX2R8agAuRwCjxdp3GGwV_zjNc8m15D8jOnOM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69055682</pqid></control><display><type>article</type><title>Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma</title><source>MEDLINE</source><source>Sage Journals GOLD Open Access 2024</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>CORTE, M. D ; GONZALEZ, L. O ; CORTE, M. G ; QUINTELA, I ; PIDAL, I ; BONGERA, M ; VIZOSO, F</creator><creatorcontrib>CORTE, M. D ; GONZALEZ, L. O ; CORTE, M. G ; QUINTELA, I ; PIDAL, I ; BONGERA, M ; VIZOSO, F</creatorcontrib><description>Matrix metalloproteases (MMPs), enzymes with the ability to degrade the extracellular matrix, play an important role in tissue invasion by cutaneous malignant melanoma (CMM). One specific MMP, collagenase-3 (MMP-13), is thought to have a key function in the activation of MMP.
To evaluate the expression of MMP-13 in CMM and assess its possible relationship to clinical and pathological parameters.
MMP-13 expression was analyzed in 51 paraffin-embedded tumor samples from patients with invasive CMM, ten samples from in situ melanomas, and in eight samples from benign lesions (three dermal melanocytic nevi, three compound melanocytic nevi and two atypical melanocytic nevi) using immunohistochemical techniques. The median follow-up period in patients with invasive CMM was 50 months.
Benign lesions were consistently negative for MMP-13, whereas three of the ten in situ melanomas (30%) and 23 of the 51 invasive CMMs (45%) showed positive immunostaining for MMP-13. The percentage of MMP-13-positive tumors correlated significantly and positively with the mitotic index (p=0.002) in invasive CMM. However, our results did not show any significant association between tumoral MMP-13 expression and relapse-free survival in patients with invasive CMM.
MMP-13 appears to be a factor associated with tumor aggressiveness in CMM. It seems to eliminate an important barrier not only against tumoral invasion but also against proliferation.</description><identifier>ISSN: 0393-6155</identifier><identifier>EISSN: 1724-6008</identifier><identifier>DOI: 10.1177/172460080502000407</identifier><identifier>PMID: 16398406</identifier><language>eng</language><publisher>Milano: Wichtig</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Analytical, structural and metabolic biochemistry ; Biological and medical sciences ; Child ; Collagenases - metabolism ; Disease-Free Survival ; Female ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation, Enzymologic ; Gene Expression Regulation, Neoplastic ; Humans ; Immunohistochemistry ; Investigative techniques, diagnostic techniques (general aspects) ; Male ; Matrix Metalloproteinase 13 ; Medical sciences ; Melanoma - enzymology ; Melanoma - metabolism ; Melanoma - pathology ; Middle Aged ; Skin Neoplasms - enzymology ; Skin Neoplasms - metabolism ; Skin Neoplasms - pathology</subject><ispartof>The International journal of biological markers, 2005-10, Vol.20 (4), p.242-248</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-247d4fa6e6db704b46f27772702febb290f22a7581b4d869fb11aac029dbe0bc3</citedby><cites>FETCH-LOGICAL-c441t-247d4fa6e6db704b46f27772702febb290f22a7581b4d869fb11aac029dbe0bc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27906,27907</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17395375$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16398406$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CORTE, M. D</creatorcontrib><creatorcontrib>GONZALEZ, L. O</creatorcontrib><creatorcontrib>CORTE, M. G</creatorcontrib><creatorcontrib>QUINTELA, I</creatorcontrib><creatorcontrib>PIDAL, I</creatorcontrib><creatorcontrib>BONGERA, M</creatorcontrib><creatorcontrib>VIZOSO, F</creatorcontrib><title>Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma</title><title>The International journal of biological markers</title><addtitle>Int J Biol Markers</addtitle><description>Matrix metalloproteases (MMPs), enzymes with the ability to degrade the extracellular matrix, play an important role in tissue invasion by cutaneous malignant melanoma (CMM). One specific MMP, collagenase-3 (MMP-13), is thought to have a key function in the activation of MMP.
To evaluate the expression of MMP-13 in CMM and assess its possible relationship to clinical and pathological parameters.
MMP-13 expression was analyzed in 51 paraffin-embedded tumor samples from patients with invasive CMM, ten samples from in situ melanomas, and in eight samples from benign lesions (three dermal melanocytic nevi, three compound melanocytic nevi and two atypical melanocytic nevi) using immunohistochemical techniques. The median follow-up period in patients with invasive CMM was 50 months.
Benign lesions were consistently negative for MMP-13, whereas three of the ten in situ melanomas (30%) and 23 of the 51 invasive CMMs (45%) showed positive immunostaining for MMP-13. The percentage of MMP-13-positive tumors correlated significantly and positively with the mitotic index (p=0.002) in invasive CMM. However, our results did not show any significant association between tumoral MMP-13 expression and relapse-free survival in patients with invasive CMM.
MMP-13 appears to be a factor associated with tumor aggressiveness in CMM. It seems to eliminate an important barrier not only against tumoral invasion but also against proliferation.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Collagenases - metabolism</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation, Enzymologic</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Male</subject><subject>Matrix Metalloproteinase 13</subject><subject>Medical sciences</subject><subject>Melanoma - enzymology</subject><subject>Melanoma - metabolism</subject><subject>Melanoma - pathology</subject><subject>Middle Aged</subject><subject>Skin Neoplasms - enzymology</subject><subject>Skin Neoplasms - metabolism</subject><subject>Skin Neoplasms - pathology</subject><issn>0393-6155</issn><issn>1724-6008</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkE1Lw0AYhBdRbK3-AQ-Si6KH6LvfybEUv6BFD3oO7252SyTZ1GwD-u9NbcCDp4HhmWEYQs4p3FKq9R3VTCiADCQwABCgD8h0Z6Y795BMgec8VVTKCTmJ8QOAUdDqmEyo4nkmQE3JfNHWNa5dwOhSnlyvVq8p5TeJ-9p0LsaqDUkVEttvMbi2j0mDdbUOGLZJ42oMbYOn5MhjHd3ZqDPy_nD_tnhKly-Pz4v5MrVC0G3KhC6FR-VUaTQII5RnWmumgXlnDMvBM4ZaZtSIMlO5N5QiWmB5aRwYy2fkat-76drP3sVt0VTRumH977JC5SClytgAsj1ouzbGzvli01UNdt8FhWJ3XPH_uCF0Mbb3pnHlX2R8agAuRwCjxdp3GGwV_zjNc8m15D8jOnOM</recordid><startdate>20051001</startdate><enddate>20051001</enddate><creator>CORTE, M. D</creator><creator>GONZALEZ, L. O</creator><creator>CORTE, M. G</creator><creator>QUINTELA, I</creator><creator>PIDAL, I</creator><creator>BONGERA, M</creator><creator>VIZOSO, F</creator><general>Wichtig</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20051001</creationdate><title>Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma</title><author>CORTE, M. D ; GONZALEZ, L. O ; CORTE, M. G ; QUINTELA, I ; PIDAL, I ; BONGERA, M ; VIZOSO, F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-247d4fa6e6db704b46f27772702febb290f22a7581b4d869fb11aac029dbe0bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Collagenases - metabolism</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation, Enzymologic</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Male</topic><topic>Matrix Metalloproteinase 13</topic><topic>Medical sciences</topic><topic>Melanoma - enzymology</topic><topic>Melanoma - metabolism</topic><topic>Melanoma - pathology</topic><topic>Middle Aged</topic><topic>Skin Neoplasms - enzymology</topic><topic>Skin Neoplasms - metabolism</topic><topic>Skin Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CORTE, M. D</creatorcontrib><creatorcontrib>GONZALEZ, L. O</creatorcontrib><creatorcontrib>CORTE, M. G</creatorcontrib><creatorcontrib>QUINTELA, I</creatorcontrib><creatorcontrib>PIDAL, I</creatorcontrib><creatorcontrib>BONGERA, M</creatorcontrib><creatorcontrib>VIZOSO, F</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The International journal of biological markers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CORTE, M. D</au><au>GONZALEZ, L. O</au><au>CORTE, M. G</au><au>QUINTELA, I</au><au>PIDAL, I</au><au>BONGERA, M</au><au>VIZOSO, F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma</atitle><jtitle>The International journal of biological markers</jtitle><addtitle>Int J Biol Markers</addtitle><date>2005-10-01</date><risdate>2005</risdate><volume>20</volume><issue>4</issue><spage>242</spage><epage>248</epage><pages>242-248</pages><issn>0393-6155</issn><eissn>1724-6008</eissn><abstract>Matrix metalloproteases (MMPs), enzymes with the ability to degrade the extracellular matrix, play an important role in tissue invasion by cutaneous malignant melanoma (CMM). One specific MMP, collagenase-3 (MMP-13), is thought to have a key function in the activation of MMP.
To evaluate the expression of MMP-13 in CMM and assess its possible relationship to clinical and pathological parameters.
MMP-13 expression was analyzed in 51 paraffin-embedded tumor samples from patients with invasive CMM, ten samples from in situ melanomas, and in eight samples from benign lesions (three dermal melanocytic nevi, three compound melanocytic nevi and two atypical melanocytic nevi) using immunohistochemical techniques. The median follow-up period in patients with invasive CMM was 50 months.
Benign lesions were consistently negative for MMP-13, whereas three of the ten in situ melanomas (30%) and 23 of the 51 invasive CMMs (45%) showed positive immunostaining for MMP-13. The percentage of MMP-13-positive tumors correlated significantly and positively with the mitotic index (p=0.002) in invasive CMM. However, our results did not show any significant association between tumoral MMP-13 expression and relapse-free survival in patients with invasive CMM.
MMP-13 appears to be a factor associated with tumor aggressiveness in CMM. It seems to eliminate an important barrier not only against tumoral invasion but also against proliferation.</abstract><cop>Milano</cop><pub>Wichtig</pub><pmid>16398406</pmid><doi>10.1177/172460080502000407</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0393-6155 |
| ispartof | The International journal of biological markers, 2005-10, Vol.20 (4), p.242-248 |
| issn | 0393-6155 1724-6008 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69055682 |
| source | MEDLINE; Sage Journals GOLD Open Access 2024; EZB-FREE-00999 freely available EZB journals |
| subjects | Adolescent Adult Aged Aged, 80 and over Analytical, structural and metabolic biochemistry Biological and medical sciences Child Collagenases - metabolism Disease-Free Survival Female Fundamental and applied biological sciences. Psychology Gene Expression Regulation, Enzymologic Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Investigative techniques, diagnostic techniques (general aspects) Male Matrix Metalloproteinase 13 Medical sciences Melanoma - enzymology Melanoma - metabolism Melanoma - pathology Middle Aged Skin Neoplasms - enzymology Skin Neoplasms - metabolism Skin Neoplasms - pathology |
| title | Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T10%3A23%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Collagenase-3%20(MMP-13)%20expression%20in%20cutaneous%20malignant%20melanoma&rft.jtitle=The%20International%20journal%20of%20biological%20markers&rft.au=CORTE,%20M.%20D&rft.date=2005-10-01&rft.volume=20&rft.issue=4&rft.spage=242&rft.epage=248&rft.pages=242-248&rft.issn=0393-6155&rft.eissn=1724-6008&rft_id=info:doi/10.1177/172460080502000407&rft_dat=%3Cproquest_cross%3E69055682%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69055682&rft_id=info:pmid/16398406&rfr_iscdi=true |